Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Visconte

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Cancers|March 6, 2021
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored TreatmentsSimona Pagliuca, Carmelo Gurnari, Valeria Visconte
International Journal of Molecular Sciences|November 17, 2020
Deciphering the Therapeutic Resistance in Acute Myeloid LeukemiaCarmelo Gurnari, Simona Pagliuca, Valeria Visconte
International Journal of Molecular Sciences|April 3, 2021
The Interactome between Metabolism and Gene Mutations in Myeloid MalignanciesCarmelo Gurnari, Simona Pagliuca, Valeria Visconte
Cells|November 25, 2020
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic ImplicationsHassan Awada, Bicky Thapa, Valeria Visconte
Leukemia Research|December 2, 2014
Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014Valeria Visconte, R Coleman Lindsley, Deborah Berlyne
Bioengineering (Basel, Switzerland)|October 28, 2023
Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging StrategiesLuca Guarnera, Carlos Bravo-Perez, Valeria Visconte
Seminars in Hematology|February 29, 2024
Clonal hematopoiesis and autoimmunityAshwin Kishtagari, Robert W Corty, Valeria Visconte
Seminars in Hematology|November 30, 2024
The potential promise of machine learning in myelodysplastic syndromeValeria Visconte, Jaroslaw P Maciejewski, Luca Guarnera
Biomedicines|May 25, 2024
Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant ProgressionSerena Travaglini, Massimiliano Marinoni, Valeria Visconte, et al.
Thrombosis and Haemostasis|February 16, 2005
Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?Nunzia Montuori, Valeria Visconte, Guido Rossi, et al.
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Cancers|March 6, 2021
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored TreatmentsSimona Pagliuca, Carmelo Gurnari, Valeria Visconte
International Journal of Molecular Sciences|November 17, 2020
Deciphering the Therapeutic Resistance in Acute Myeloid LeukemiaCarmelo Gurnari, Simona Pagliuca, Valeria Visconte
International Journal of Molecular Sciences|April 3, 2021
The Interactome between Metabolism and Gene Mutations in Myeloid MalignanciesCarmelo Gurnari, Simona Pagliuca, Valeria Visconte
Cells|November 25, 2020
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic ImplicationsHassan Awada, Bicky Thapa, Valeria Visconte
Leukemia Research|December 2, 2014
Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014Valeria Visconte, R Coleman Lindsley, Deborah Berlyne
Bioengineering (Basel, Switzerland)|October 28, 2023
Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging StrategiesLuca Guarnera, Carlos Bravo-Perez, Valeria Visconte
Seminars in Hematology|February 29, 2024
Clonal hematopoiesis and autoimmunityAshwin Kishtagari, Robert W Corty, Valeria Visconte
Seminars in Hematology|November 30, 2024
The potential promise of machine learning in myelodysplastic syndromeValeria Visconte, Jaroslaw P Maciejewski, Luca Guarnera
Biomedicines|May 25, 2024
Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant ProgressionSerena Travaglini, Massimiliano Marinoni, Valeria Visconte, et al.
Thrombosis and Haemostasis|February 16, 2005
Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?Nunzia Montuori, Valeria Visconte, Guido Rossi, et al.
Pageof 16